Inhibrx, Inc.

Inhibrx, Inc. mission is to deliver optimized, biologic therapeutics to people with life-threatening conditions. Toward this goal, they have built a large and diverse pipeline with the potential to impact cancer and orphan diseases through their single domain antibody platform technology. Single domain antibodies (sdAbs) provide a small, simple, modular target binding domain that can be…More combined in a variety of ways to meet specific needs of unique biological targets. Their sdAb-based therapeutic candidates have been designed to interface with the biology of each target antigen, and can be readily manufactured at high yields with established processes.